| Identification | Back Directory | [Name]
Prolgolimab | [CAS]
2093956-19-3 | [Synonyms]
Prolgolimab
Research Grade Prolgolimab
Research Grade Prolgolimab (DHH02217) |
| Hazard Information | Back Directory | [Uses]
Prolgolimab (BCD-100) is a human IgG1 anti-PD-1 monoclonal antibody containing the Fc-silencing 'LALA' mutation. Prolgolimab can be used for the research of advanced melanoma[1]. | [References]
[1] Tjulandin S, et, al. Novel PD-1 inhibitor prolgolimab: expanding non-resectable/metastatic melanoma therapy choice. Eur J Cancer. 2021 May;149:222-232. DOI:10.1016/j.ejca.2021.02.030 |
|
| Company Name: |
Biolab Reagents
|
| Tel: |
18108604356 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
Cell Sciences
|
| Tel: |
9785721070 |
| Website: |
www.cellsciences.com |
|